LATEST PRESS RELEASE

 

Medical Cannabis Seminars for Patients and Carers

Medical Cannabis for Patients and CarersDuring September we are touring the country educating the public this time about medicinal cannabis. After our hugely popular lecture tour in May for health professionals, we saw the need to do it all again with a slightly different focus. Seminars are organized in conjunction with Epilepsy Action Australia and are being held in Melbourne, Sydney, Brisbane, and Perth from the 11th to the 14th of September. Please click here or see the attached flyer for more info. Early bird tickets are only $25.

Medicinal cannabis was legalized in Australia in November 2016.

The global legal cannabis market is expected to grow to over US$20 billion by 2020.

There is good clinical evidence that it may be of benefit in Chronic Pain, MS, Nausea in Cancer Related Chemotherapy and Intractable Epilepsy.

Come and learn how your medical condition may be treated by medicinal cannabis.

Book tickets to the Sydney seminar on Tuesday 9 May here: www.trybooking.com/303189

You can check out the event on Facebook: https://www.facebook.com/events/1921865924720496

It will be an amazing night with some fantastic speakers including:

Paul Mavor - Health House International
Paul is an Australian based pharmacist who has been researching the potential of medicinal cannabis as a treatment for several years. His company was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Paul brings a wealth of knowledge from his hands-on research in the U.S., Canada, and Israel. www.healthhouse.com.au 

Justin Sinclair

Justin is a Pharmacognosist & Educator and has spent decades exploring the diverse field of herbal medicine, both from a scientific and traditional ethnopharmacological perspective. Working in education since 2003, Justin has taught across a wide variety of subjects encompassing medical sciences such as anatomy, physiology, integrated pharmacology and clinical pathology to plant specific sciences such as pharmacognosy / phytochemistry, herbal manufacturing, and medicinal botany. He has worked as a research and development consultant to the educational and healthcare industries since 2006. Key areas of study in his Master's degree with the Faculty of Pharmacy at Sydney University were toxicology, pharmacognosy, analytical phytochemistry, medicinal botany and pharmaceutical technology. Over the last decade, his research interests encompass Medicinal Cannabis, cannabinoid based pharmacology, novel drug development, full spectrum plant extracts and plant based pharmacology for pain, inflammation and immune modulation. His current clinical interests include pain management, mental health disorders and herb drug interactions. www.tmconsultancy.com.au

Associate Professor Jonathon Arnold - Lambert Initiative for Cannabinoid Therapeutics (Sydney University)
Jonathon is in charge of pre-clinical research at Lambert and has published over 60 research papers that have received more than 2000 citations. His first major discovery was that plant cannabinoids reverse resistance to anticancer drugs. He has also isolated several genes that modulate the effects of cannabinoids on the brain and contributed to Australia’s first cannabis potency study, showing that Australian street cannabis is among the most potent in the world. More recently he has published research on interplay between CBD and THC which may contribute to the "entourage effect". www.sydney.edu.au/lambert/

Ben Oakley- Patient Advocate
Ben is one of only 20 people in Australia suffering from "Stiff Person Syndrome". He will explain his journey and his fight to access medicinal cannabis. www.chuffed.org/project/drop-a-dollar

A representative from Epilepsy Action
Established in 1952, Epilepsy Action Australia undertakes research and advocacy and delivers innovative, high-quality services across Australia to optimize life outcomes for people with epilepsy. The organisation's aims are to increase epilepsy awareness and understanding in the community and facilitate self-management of epilepsy for people with the condition. www.epilepsy.org.au

Epilepsy Action

 

 

 


Cape to Cape for Alzheimer’s Research

Cape to Cape for Alzheimers MCRA are organising a charity walk in South West WA to raise money for Alzheimer’s research using medicinal cannabis as a potential treatment. This is over 6 days in October and covers 135km from Cape Naturaliste to Cape Leeuwin along some beautiful coastline. Gourmet snack hampers and lunches will be provided daily. Transfers and insurance are included. Tickets are available via Trybooking and there is a flyer attached There has been a number of low-level studies showing medicinal cannabis may be of benefit for Alzheimer’s patients. Alzheimer’s is thought to affect 1 person in 10 above the age of 65. There are very few treatments and no cure. We consider this to be a very worthwhile project. If you can’t attend this event please consider donating.
 


Medical Cannabis on the ABC 7.30 Report

ABC 7.30 ReportRecently the plights of the parents of two Australian medicinal cannabis patients were featured on national TV. Access needs to improve for patients and we have been lobbying politicians to streamline the process. The Therapeutic Goods Administration (TGA) at a federal level regulate medicines really well. The additional state regulations are an unnecessary hurdle that chronically ill patients and their prescribers need to navigate. We are hoping in the near future to reduce some of the red tape.


Donations of any size are welcome, and we encourage you learn more about our charity and the work we do by visiting our website: www.mcra.org.au

Thank you for your support!

Medical Cannabis Research Australia
  Like us on Facebook 

info@mcra.org.au
www.mcra.org.au